This lecture explores the governance of precision medicine, focusing on the trust, economics, and value aspects. It delves into the challenges and benefits of precision medicine, emphasizing the importance of trust in data collection, analysis, and new medical care. The lecture also discusses real-world projects like the FinGenn project in Scandinavia and the NIH's All of Us Research Program, highlighting the significance of trust and transparency in large-scale health data initiatives.